6 - 10 из 671
24 августа 2020

Bruker and Purity-IQ sign partnership agreement to transform the cannabis regulatory landscape

BILLERICA, Massachusetts – August 24, 2020: Bruker and Purity-IQ have joined forces to create a powerful new testing system for medical cannabis in Canada. The Purity-IQ Cannabis Fingerprint™ combines Bruker’s expertise in nuclear magnetic resonance (NMR) based screening technology with Purity-IQ’s genomics capabilities to offer traceability and identity testing throughout the cannabis supply chain.

13 августа 2020

Cutting-Edge micro-CT Imaging Research Shines New Light on Mooted SARS-CoV-2 Treatments

BILLERICA, Massachusetts – August 13 , 2020 – Following the recent installation of Bruker’s SkyScan 1278 in vivo micro-CT system, researchers at the KU Leuven, Belgium, have published pioneering research that provides information about the ongoing search for effective treatments against COVID-19.

10 августа 2020

Bruker Supports International Covid19-NMR Consortium for Structure-Function and Inhibitor Binding Investigations of SARS-CoV-2 RNA and Proteins

FRANKFURT, Germany--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) today announced its support of a worldwide collaborative project that investigates the structures, dynamics, function and binding of SARS-CoV-2 viral RNA and proteins using high-field nuclear magnetic resonance (NMR) spectroscopy.

3 августа 2020

Bruker Reports Second Quarter 2020 Financial Results

BILLERICA, Mass.--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) today announced financial results for its second quarter and for the six months ended June 30, 2020.